Skip to content

13F-HR/A filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR/A for the quarter ended 2016-03-31, filed 2016-05-16, with 51 holding rows worth $176,720,000.

Accession
0001387131-16-005579
Filed
2016-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2016

A holdings report, amendment of type restatement, 51 entries on the cover page, a total value of $176,720,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $176,720,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR SER TR78464A870S&P BIOTECH220,000$11,037,000thousands by filing dateput
ACADIA PHARMACEUTICALS INC004225108COM350,000$9,786,000thousands by filing dateput
CELGENE CORP151020104COM90,202$9,028,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock100,000$8,821,000thousands by filing datecall
Boston Scientific Corporation101137107COM450,000$8,465,000thousands by filing date
iShares Russell 2000 ETF464287655SHS75,000$8,297,000thousands by filing dateput
HORIZON PHARMA PLCG4617B105SHS425,000$7,042,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock700,000$5,950,000thousands by filing date
AbbVie,Inc.00287Y109COM100,000$5,712,000thousands by filing datecall
AGIOS PHARMACEUTICALS INC00847X104COM140,000$5,684,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM40,000$5,569,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR100,000$5,351,000thousands by filing datecall
MIRATI THERAPEUTICS INC60468T105COM250,000$5,350,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM160,000$5,130,000thousands by filing date
SPECTRANETICS CORP84760C107COM350,000$5,082,000thousands by filing date
OPHTHOTECH CORP683745103COM120,000$5,072,000thousands by filing date
ISHARES TR464288828US HLTHCR PR ETF39,500$4,818,000thousands by filing date
NEVRO CORP64157F103COM75,000$4,220,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM225,000$3,425,000thousands by filing date
NUVASIVE INC670704105COM70,000$3,406,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW50,000$3,368,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM40,000$3,299,000thousands by filing date
iShares U.S. Medical Devices ETF464288810SHS25,000$3,062,000thousands by filing date
RESMED INC COM761152107Stock50,000$2,891,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM100,000$2,630,000thousands by filing datecall
DBV TECHNOLOGIES S A23306J101ADR45,000$2,583,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM75,000$2,097,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS125,000$2,075,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock100,000$2,040,000thousands by filing datecall
ST JUDE MED INC790849103COM36,500$2,008,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM25,253$2,007,000thousands by filing date
ENTELLUS MED INC29363K105COM110,000$2,001,000thousands by filing date
Medtronic PlcG5960L103COM26,578$1,993,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM250,000$1,930,000thousands by filing date
VERACYTE INC COM92337F107Stock341,708$1,845,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR151,535$1,803,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM300,000$1,581,000thousands by filing date
ISHARES TR464288836U.S. PHARMA ETF9,800$1,342,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM150,000$1,307,000thousands by filing date
Lion Biotechnologies53619R102COM250,000$1,270,000thousands by filing date
Alcobra LtdM2239P109SHS300,000$1,137,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock40,000$816,000thousands by filing date
CHIASMA INC16706W102COM75,000$687,000thousands by filing date
ENDO INTL PLCG30401106SHS24,100$678,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM101,188$671,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR46,622$653,000thousands by filing date
HERON THERAPEUTICS INC427746102COM25,000$475,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR50,000$407,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM18,500$355,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD72,726$332,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM45,000$132,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-16-005476 superseded2016-05-13acceptance time not in the bulk data set
13F-HR/A 0001387131-16-005579this filing2016-05-16acceptance time not in the bulk data set